XML 28 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share.
6 Months Ended
Jun. 30, 2021
Earnings Per Share [Abstract]  
EARNINGS PER SHARE.
10.EARNINGS PER SHARE.

 

The following tables compute basic and diluted earnings per share (in thousands, except per share data):

 

   Three Months Ended June 30, 2021 
   Income
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net income attributed to Alto Ingredients, Inc.  $8,390           
Less: Preferred stock dividends   (315)          
Basic income per share:               
Income available to common stockholders  $8,075    71,260   $0.11 
Add: Dilutive instruments       669      
Diluted income per share:               
Income available to common stockholders  $8,075    71,929   $0.11 

 

   Three Months Ended June 30, 2020 
   Income
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net income attributed to Alto Ingredients, Inc.  $14,964           
Less: Preferred stock dividends   (315)          
Basic and diluted income per share:               
Income available to common stockholders  $14,649    54,498   $0.27 

 

   Six Months Ended June 30, 2021 
   Income
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net income attributed to Alto Ingredients, Inc.  $13,068           
Less: Preferred stock dividends   (627)          
Basic income per share:               
Income available to common stockholders  $12,441    70,808   $0.18 
Add: Dilutive instruments       1,153      
Diluted income per share:               
Income available to common stockholders  $12,441    71,961   $0.17 

 

   Six Months Ended June 30, 2020 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss attributed to Alto Ingredients, Inc.  $(10,136)          
Less: Preferred stock dividends   (630)          
Basic and diluted loss per share:               
Loss available to common stockholders  $(10,766)   54,163   $(0.20)

 

There were an additional aggregate potentially dilutive weighted-average shares of 964,000 from convertible securities outstanding for the three and six months ended June 30, 2021 and 2020. These securities were not considered in calculating diluted net income (loss) per share for the three and six months ended June 30, 2021 and 2020, as their effect would have been anti-dilutive.